{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/8c560a52-84ff-4b06-b819-f4e9bd6e85ef/6afd584809470f94204a6c99?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Did gold stop working, Anthropic’s IPO explained & Pimp my Portfolio with Luke Laretive","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/6113c4e58b49030d2716f6e0/1794991630636-4b08a294-e18a-4edc-8128-71c6eedb2672.jpeg?height=200","description":"<p>Gold is meant to protect you from inflation. So why has it crashed more than 30% while inflation keeps climbing? Bryce &amp; Ren unpack what&#39;s going wrong for the world&#39;s favourite safe haven, before diving into Novo Nordisk&#39;s controversial weight-loss drug trials involving children. Then it&#39;s the IPO everyone&#39;s talking about: Anthropic is heading to the NASDAQ at a staggering $1.4 trillion valuation. Is it a generational investment opportunity, or should investors wait for the hype to settle? Plus, Luke Laretive returns for Pimp My Portfolio, helping one investor rethink an 80% allocation to just two mining stocks.</p><p><br></p><p><strong>In this episode:</strong></p><p>00:00 Gold, Anthropic &amp; what&#39;s coming up</p><p>03:16 Gold crashes 31%: Is the inflation hedge broken?</p><p>09:07 Ozempic for kids? Inside Novo Nordisk&#39;s obesity trials</p><p>14:42 Should you buy Anthropic at IPO?</p><p>16:56 Anthropic&#39;s financials &amp; the SpaceX comparison</p><p>22:07 Why investors should think twice before buying an IPO</p><p>25:38 When will Anthropic enter the US indexes?</p><p>29:30 Pimp My Portfolio with Luke Laretive</p><p><br></p><p>Stocks &amp; ETFs Mentioned: Anthropic (NASDAQ: ANT), SpaceX, Novo Nordisk (NYSE: NVO), Eli Lilly (NYSE: LLY), Meta Platforms (NASDAQ: META), Uber Technologies (NYSE: UBER), Spotify Technology (NYSE: SPOT), SK Hynix (KRX: 000660), Quantium (NASDAQ: QNT), INEO (NASDAQ: INEO), Bending Spoons (NASDAQ: BSP), Berkshire Hathaway (NYSE: BRK.B), Minerals 260 (ASX: MI6), Brightstar Resources (ASX: BTR), Vanguard Australian Shares Index ETF (ASX: VAS), Vanguard MSCI Index International Shares ETF (ASX: VGS), iShares Asia 50 ETF (ASX: IAA), Betashares Nasdaq 100 ETF (ASX: NDQ)</p><p><br></p><p>Join our team! Apply for our Research Analyst &amp; Content Writer Position with Equity Mates <a href=\"https://employmenthero.com/jobs/position/betashares-research-analyst-writer-equity-mates-luex9/\" rel=\"noopener noreferrer\" target=\"_blank\">here</a></p><p><br></p><p>———</p><p><br></p><p>Want to get involved in the podcast? Record a <a href=\"https://tinyurl.com/4uw5f58j\" rel=\"noopener noreferrer\" target=\"_blank\">voice note</a> or <a href=\"https://tinyurl.com/2hyfsrw7\" rel=\"noopener noreferrer\" target=\"_blank\">send us a message</a></p><p><br></p><p>And come and join the conversation in the Equity Mates <a href=\"https://www.facebook.com/groups/equitymates/\" rel=\"noopener noreferrer\" target=\"_blank\">Facebook Discussion Group</a>.</p><p><br></p><p>———</p><p><br></p><p>Want more Equity Mates? Across books, podcasts, video and email, however you want to learn about investing – <a href=\"https://linktr.ee/equitymates\" rel=\"noopener noreferrer\" target=\"_blank\">we’ve got you covered</a>.</p><p>Keep up with the news moving markets with our <a href=\"https://tinyurl.com/2saau2ky\" rel=\"noopener noreferrer\" target=\"_blank\">daily newsletter</a> and podcast (<a href=\"https://tinyurl.com/yxm3mm2c\" rel=\"noopener noreferrer\" target=\"_blank\">Apple</a> | <a href=\"https://tinyurl.com/299dedpd\" rel=\"noopener noreferrer\" target=\"_blank\">Spotify</a>)</p><p>We’re particularly excited to share our latest show: Basis Points</p><p>Listen to the podcast (<a href=\"https://tinyurl.com/2zmumf7v\" rel=\"noopener noreferrer\" target=\"_blank\">Apple</a> | <a href=\"https://tinyurl.com/mr4x8tae\" rel=\"noopener noreferrer\" target=\"_blank\">Spotify</a>)</p><p>Watch on <a href=\"https://tinyurl.com/yc596wem\" rel=\"noopener noreferrer\" target=\"_blank\">YouTube</a></p><p>Read the <a href=\"https://basispoints.beehiiv.com/\" rel=\"noopener noreferrer\" target=\"_blank\">monthly email</a></p><p><br></p><p>———</p><p><br></p><p>Looking for some of our favourite research tools?</p><p>Download our free <a href=\"https://tinyurl.com/7k2z7ebx\" rel=\"noopener noreferrer\" target=\"_blank\">Basics of ETF handbook</a></p><p>Or our free <a href=\"https://tinyurl.com/4zjkm3pt\" rel=\"noopener noreferrer\" target=\"_blank\">4-step stock checklist</a></p><p>Find company information on <a href=\"https://www.tikr.com/?ref=equitymates\" rel=\"noopener noreferrer\" target=\"_blank\">TIKR</a></p><p>Research reports from <a href=\"https://goodresearch.com.au/ref/equitymates/\" rel=\"noopener noreferrer\" target=\"_blank\">Good Research</a></p><p>Track your portfolio with <a href=\"https://www.sharesight.com/au/equitymates/\" rel=\"noopener noreferrer\" target=\"_blank\">Sharesight</a></p><p><br></p><p>———</p><p><br></p><p>This podcast is intended for education and entertainment purposes only. Any advice is general advice and has not taken into account your personal financial circumstances. Before acting on general advice, you should consider if it is relevant to your needs. If unsure, speak to a financial professional. The host of this podcast and their guests may have positions in the companies mentioned. Equity Mates Media is part of the Betashares Group but maintains editorial independence and operates under Australian Financial Services licence 540697.</p>","author_name":"Equity Mates Media"}